SS
ABCL icon

SBI Securities’s AbCellera Biologics ABCL Stock Holding History

SBI Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.8K Buy
8,528
+5,901
+225% +$21.2K ﹤0.01% 1301
2025
Q4 		$8.98K Sell
2,627
-655
-20% -$2.92K ﹤0.01% 1758
2025
Q3 		$16.5K Sell
3,282
-2,361
-42% -$10.4K ﹤0.01% 1535
2025
Q2 		$19.4K Buy
5,643
+2,723
+93% +$6.78K ﹤0.01% 1421
2025
Q1 		$6.51K Buy
2,920
+529
+22% +$1.52K ﹤0.01% 1789
2024
Q4 		$7.01K Buy
+2,391
New +$6.66K ﹤0.01% 1791

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return